Jan Tore Gran
Overview
Explore the profile of Jan Tore Gran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garen T, Lerang K, Hoffmann-Vold A, Andersson H, Midtvedt O, Brunborg C, et al.
Rheumatology (Oxford)
. 2018 Oct;
58(2):313-320.
PMID: 30281089
Objectives: Studies assessing relative mortality risks across the spectrum of systemic inflammatory rheumatic diseases are largely missing. In this study, we wanted to estimate standard mortality ratios (SMRs) and causes...
2.
Dobloug G, Garen T, Brunborg C, Gran J, Molberg O
Semin Arthritis Rheum
. 2015 Jul;
45(3):301-8.
PMID: 26190563
Objective: To utilise an exposed/unexposed cohort strategy for mortality and cancer analyses across unselected and complete cohorts of patients with idiopathic inflammatory myopathy (IIM) resident in south-east Norway (denominator population...
3.
Hoffmann-Vold A, Aalokken T, Lund M, Garen T, Midtvedt O, Brunborg C, et al.
Arthritis Rheumatol
. 2015 Apr;
67(8):2205-12.
PMID: 25916462
Objective: Systemic sclerosis (SSc) carries a high risk of progressive interstitial lung disease (ILD), but tools for stratifying individual risk are scarce. The purpose of this study was to assess...
4.
Midtvedt O, Gran J, Solheim H, Kirkhus E, Spetalen S
Tidsskr Nor Laegeforen
. 2014 Oct;
134(19):1823.
PMID: 25314975
No abstract available.
5.
Midtvedt O, Gran J, Solheim H, Kirkhus E, Spetalen S
Tidsskr Nor Laegeforen
. 2014 Aug;
134(15):1472-6.
PMID: 25138406
Unlabelled: Erdheim-Chester disease. A multi-disiplinary challenge. The histiocytoses are a diverse, but rare group of disorders with symptoms affecting many organs, varying from self-limiting, localised lesions to disseminated multi-organ disease....
6.
Dobloug C, Garen T, Bitter H, Stjarne J, Stenseth G, Grovle L, et al.
Ann Rheum Dis
. 2014 Apr;
74(8):1551-6.
PMID: 24695011
Objectives: The occurrence of polymyositis (PM) and dermatomyositis (DM) in the general population is largely unknown and unbiased data on clinical and laboratory features in PM/DM are missing. Here, we...
7.
Hoffmann-Vold A, Molberg O, Midtvedt O, Garen T, Gran J
J Rheumatol
. 2013 May;
40(7):1127-33.
PMID: 23637316
Objective: To determine survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis (SSc) compared to the background population. Methods: Multiple methods were...
8.
Gunnarsson R, Andreassen A, Molberg O, Lexberg A, Time K, Dhainaut A, et al.
Rheumatology (Oxford)
. 2013 Feb;
52(7):1208-13.
PMID: 23407386
Objectives: The aim of this study was to assess the overall prevalence of pulmonary hypertension (PH) in an unselected MCTD cohort and review the current knowledge with a systematic database...
9.
Palm O, Garen T, Enger T, Jensen J, Lund M, Aalokken T, et al.
Rheumatology (Oxford)
. 2012 Nov;
52(1):173-9.
PMID: 23192906
Objective: The aim of the present study was to describe the prevalence of clinical pulmonary manifestations in primary SS (pSS), and based on registry data, to assess quality of life...
10.
Dobloug C, Walle-Hansen R, Gran J, Molberg O
Clin Exp Rheumatol
. 2012 Sep;
30(6):838-42.
PMID: 22935197
Objectives: Previous studies of intravenous immunoglobulin (IVIG) treatment in sporadic inclusion body myositis (sIBM) have yielded conflicting results. Here, we have undertaken a retrospective assessment of the long-term effects of...